Rosen Quoted in Inside Health Policy About DeLaura, Bishop Relationship and FDA Spending Decisions
December 10, 2020
Inside Health Policy
Partner David Rosen was quoted in the Inside Health Policy article, “DeLauro, Bishop Relationship Could Enhance FDA Approps,” about how incoming House Appropriations Committee Chair Rosa DeLauro (D-CT) could play a key role in FDA-related spending decisions due to her close dealings with Rep. Sanford Bishop (D-GA), who heads the FDA appropriations subcommittee that DeLauro has previously chaired.
Rosen told IHP that DeLauro’s interest in increasing access to medical products and engagement in the FDA regulatory process will make her a good committee chair.
(Subscription required.)
People
Related News
May 8, 2026
In the News
Shannon Goff Kukulka Highlighted Across Media for Foley Arrival
Foley & Lardner LLP partner Shannon Goff Kukulka is featured across media for her recent arrival to the firm's Nashville office.
May 4, 2026
In the News
James Lundy Assesses SEC Disgorgement Issues in Key Supreme Court Case
Foley & Lardner LLP partner James Lundy assessed the U.S. Supreme Court’s consideration of SEC disgorgement powers in the Bloomberg Law article, “SEC Win on Core Enforcement Tool Would Still Leave Payback Gaps.”
May 1, 2026
In the News
Kathryn Trkla Shares Insights on Evolution of US Derivatives Law
Foley & Lardner LLP partner Kathryn Trkla spoke to John Lothian News to share insights from co-authoring the latest edition of Derivatives Regulation, the leading authority on U.S. derivatives law.